SCHEMBL21167509

SCHEMBL21167509

COc1ccc(-c2cnc(N)c(NCc3ccc4nccn4c3)n2)cn1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 5/20 0.42
HDAC1 Q13547 1/20 0.40
LDHA P00338 1/20 0.39
LDHB P07195 1/20 0.39
MET P08581 3/20 0.39
KEAP1 Q14145 1/20 0.39
CSF1R P07333 1/20 0.39
ATR Q13535 1/20 0.39
CYP11B1 P15538 1/20 0.38
TRIM33 Q9UPN9 3/20 0.37
PIK3CA P42336 1/20 0.37
CD63 P08962 1/20 0.37
SYK P43405 1/20 0.37
DYRK1A Q13627 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22475989 0.90 NAMPT (0.41) NAMPTHDAC1METKEAP1CYP11B1
SCHEMBL21167350 0.89 TRIM33 (0.42) NAMPTLDHALDHBMETKEAP1
SCHEMBL21167452 0.83 MET (0.54) NAMPTLDHALDHBMETKEAP1
SCHEMBL21167380 0.83 DYRK1A (0.44) NAMPTLDHALDHBMETKEAP1
SCHEMBL21167775 0.83 MET (0.57) NAMPTHDAC1LDHALDHBMET
SCHEMBL21167421 0.82 CSF1R (0.59) LDHALDHBMETKEAP1CSF1R
SCHEMBL24590985 0.80 MET (0.46) METCSF1RPIK3CASYK
SCHEMBL22475658 0.80 CSF1R (0.46) LDHALDHBMETKEAP1CSF1R
SCHEMBL22095502 0.79 KEAP1 (0.49) NAMPTHDAC1KEAP1TRIM33DYRK1A
SCHEMBL21167673 0.79 CSF1R (0.45) NAMPTLDHALDHBMETKEAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3795573-B1 CERTAIN TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR HUTCHISON MEDIPHARMA LTD (CN) 2022-07-06 EP disclosed
EP-3795573-A1 CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRIDINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR Hutchison Medipharma Limited (CN) 2021-03-24 EP disclosed
EP-3511330-B1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS HUTCHISON MEDIPHARMA LTD (CN) 2020-09-30 EP disclosed
EP-3511330-A1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS Hutchison Medipharma Limited (CN) 2019-07-17 EP disclosed